Jeet Mukherjee

Stock Analyst at BTIG

(2.16)
# 3,276
Out of 5,134 analysts
179
Total ratings
39.1%
Success rate
0.7%
Average return
Main Sectors:

Stocks Rated by Jeet Mukherjee

Foghorn Therapeutics
Nov 10, 2026
Maintained: Hold
Price Target: n/a
Current: $2.04
Upside: -
ImmunityBio
Nov 10, 2026
Maintained: Buy
Price Target: $12
Current: $7.11
Upside: +68.90%
Perspective Therapeutics
Nov 10, 2026
Maintained: Buy
Price Target: $14
Current: $0.8585
Upside: +1,530.75%
ArriVent BioPharma
Nov 10, 2026
Maintained: Buy
Price Target: $29
Current: $14.16
Upside: +104.80%
Bicara Therapeutics
Nov 10, 2026
Maintained: Buy
Price Target: $39 → $37
Current: $9.99
Upside: +270.37%
Faeth Therapeutics
Nov 9, 2026
Reiterated: Buy
Price Target: $55
Current: $12.67
Upside: +334.10%
Ascentage Pharma Group International
Nov 5, 2026
Reiterated: Buy
Price Target: $48
Current: $15.36
Upside: +212.50%
Innate Pharma
Nov 5, 2026
Reiterated: Buy
Price Target: $9
Current: $1.47
Upside: +512.24%
Palvella Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $215
Current: $175.07
Upside: +22.81%
Quoin Pharmaceuticals
Nov 5, 2026
Reiterated: Buy
Price Target: $14
Current: $3.91
Upside: +258.51%
Reiterated: Buy
Price Target: $18
Current: $6.76
Upside: +166.27%
Reiterated: Buy
Price Target: $32
Current: $16.13
Upside: +98.39%
Reiterated: Buy
Price Target: $24
Current: $8.69
Upside: +176.18%
Reiterated: Buy
Price Target: $139
Current: $139.18
Upside: -0.13%
Reiterated: Buy
Price Target: $125
Current: $28.98
Upside: +331.33%
Reiterated: Buy
Price Target: $26
Current: $9.22
Upside: +182.00%
Reiterated: Hold
Price Target: n/a
Current: $1.36
Upside: -
Reiterated: Buy
Price Target: $117 → $133
Current: $73.31
Upside: +81.42%
Reiterated: Hold
Price Target: n/a
Current: $7.56
Upside: n/a
Reiterated: Buy
Price Target: $91
Current: $24.32
Upside: n/a
Reiterated: Buy
Price Target: $12
Current: $0.1828
Upside: n/a
Initiated Coverage: Buy
Price Target: $42
Current: $51.55
Upside: n/a
Reiterated: Buy
Price Target: $100
Current: $12.76
Upside: n/a
Reiterated: Buy
Price Target: $62
Current: $32.03
Upside: n/a
Reiterated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a